|
| Encounter |
D0067
|
Determination ID
|
Newborn Screening Ontario (NSO), NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Unique number linked to test ID and result flag
|
D0078
|
Parents/Health Care Provider informed of positive newborn screen result
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Have the parents or the infant's health care provider been informed of the positive newborn screen result
|
D0078DATE
|
Parents/Health Care Provider informed of positive newborn screen result Date
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
|
D0131
|
Ascertainment of newborn screening missed cases
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The way by which an individual affected with an NSO targeted disease came to medical attention.
Pick List Value:
Family history / Cascade testing
|
D0131-01
|
Ascertainment symptoms
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The symptom(s) that lead to the diagnosis of a newborn screening target disease in an infant who was not ascertained by newborn screening
|
D0131-02
|
Ascertainment other
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The reason(s) that lead to the diagnosis of a newborn screening target disease in an infant who was not ascertained by newborn screening excluding family history, cascade testing, symptoms and post-mortem investigations.
|
FAN1001
|
Genetic Testing Type (Maternal / Paternal)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
See "Molecular Genetic Testing" & "Karyotype Genetic Testing" tabs
|
MDERFMCACC
|
Missed case NSO_accession_num
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The NSO accession number as recorded on the symptomatic diagnosis report form
|
MMMSS0091
|
Centre for Follow-Up Services
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Name of the clinical centre that provided follow-up counselling services following the disclosure of the maternal serum screen result.
|
N0005
|
Birth Location
|
Birth Child (BC), Healthy Babies Healthy Children (HBHC), Labour & Birth Mother (LBM), Newborn Screening Ontario (NSO), Neonatal Intensive Care Unit (NICU), NSO Diagnostic Evaluation Report Form (DERF), Postpartum Child (PPC), Postpartum Mother (PPM)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Location where the birth occurred (hospital, home, other, etc.).
|
NBS0013
|
Date of NSO target disease symptom onset
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Date of symptom onset for NSO target disease
|
NBS0014
|
Date of Definitive Diagnosis
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Date of definitive diagnosis for the infant / child. This may differ from the date that the diagnosis was communicated to the family / health care provider.
|
NBS0015
|
Parent Diagnosed Prior to Positive NSO Screen Flag
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Indicates whether the mother was diagnosed prior to the positive newborn screen obtained for the infant.
|
NBS0016
|
Date of infant retrieval for diagnostic evaluation after positive Newborn Screen
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
As reported by regional treatment centre, the date when the screen positive baby was located and diagnostic evaluation begun.
|
NBS0017
|
Date of First Contact with Family / MD in regards to positive Newborn Screen
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
As reported by the treatment centre, the date of that provider or family made aware of positive newborn screen result
|
NBS0018
|
Definitive diagnosis after diagnostic evaluation and follow up
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Diagnosis made in the infant / child (or mother) following clinical and / or diagnostic evaluations
Pick List Value:
Presumed carrier - Not confirmed in dx lab
21-Hydroxylase Deficiency: Non-classical
21-Hydroxylase Deficiency: Salt Wasting
21-Hydroxylase Deficiency: Simple Virilizing
2-methyl-3-hydroxybutyryl CoA dehydrogenase deficiency
3-Methylglutaconic aciduria Type 1 (3-methylglutaconyl-CoA hydratase deficiency)
3-Methylglutaconic aciduria Type 2 (Barth Syndrome)
3-Methylglutaconic aciduria Type 3 (Costeff optic atrophy)
3-Methylglutaconic aciduria Type 4
3-Methylglutaconic aciduria Type 5 (Dilated cardiomyopathy with ataxia)
Beta-kethothiolase deficiency - Variant
HMGCoA Lyase Deficiency - Variant
3-MCC deficiency - Variant
2-methyl-3hydroxybutyryl CoA dehydrogenase deficiency - Variant
Holocarboxylase synthase deficiency - Variant
3-Methylglutaconic aciduria Type 1 (3-methylglutaconyl-CoA hyratase deficiency) - Variant
3-Methylglutaconic aciduria Type 2 (Bath Syndrome) - Variant
3-Methylglutaconic aciduria Type 3 (Costeff optic atrophy) - Variant
3-Methylglutaconic aciduria Type 4 - Variant
3-Methylglutaconic aciduria Type 5 (Dialted cardiomyopathy w/ ataxia) - Variant
Maternal mitochondrial dysfunction
CPT2 deficiency - Variant
Beta-ketothiolase deficiency
Carnitine transporter defect
Carnitine transporter defect - Variant
Maternal carnitine deficiency
Classical PKU (Phe >= 1200)
Moderate PKU (Phe 900-1199)
Mild hyperphenylalaninemia (gray zone) (Phe 360-599)
Mild hyperphenylalaninemia (benign) (Phe 120-359)
Other known cause of TSH elevation, specify:
GTP Cyclohydrolase Deficiency
Maternal Disease: Maternal PTU/Graves Disease
Maternal Disease: Thyroid blocking antibodies
GTP Cyclohydrolase Deficiency - Variant
PTPS Deficiency - Variant
CH Undetermined: Presumed Dysgenesis or Dyshormonogenesis
CH Idiopathic: Overt (TSH ≥ 30)
CH Idiopathic: Overt (TSH < 30)
CH Idiopathic: Compensated (TSH ≥ 30)
CH Idiopathic: Compensated (TSH < 30)
Citrullinemia (ASA synthetase deficiency)
Citrullinemia Type II (Citrin deficiency)
Propionic acidemia - Variant
Methylmalonyl CoA Mutase deficiency - Variant
Methylmalonyl CoA Mutase deficiency (B12 responsive) - Variant
CPT1 deficiency - Inuit Variant
Glutaric Aciduria Type I low excretor
Glutaric Aciduria Type II
Glycine N-Methyltransferase Deficiency
Holocarboxylase synthase deficiency
Maternal 3-MCC deficiency
Maternal biotin deficiency
Maternal carnitine transporter defect
Maternal other (Specify:)
Maternal Vitamin B12 deficiency
Methionine Adenosyltransferase Deficiency
Methylmalonyl CoA mutase deficiency
Methylmalonyl CoA mutase deficiency (B12 responsive)
Mitochondrial trifunctional protein deficiency
LCHAD deficiency - Variant
Mitochondrial trifunctional protein deficiency - Variant
Glutaric Aciduria Type II - Variant
Partial Biotinidase Deficiency
Profound Biotinidase Deficiency
S-Adenosylhomocysteine Hydrolase
SAM transferase deficiency
Secondary carnitine deficiency
Type 1 Tyrosinemia (FAH deficiency)
Type 2 Tyrosinemia (TAT deficiency)
Type 1 Tyrosinemia (FAH deficiency) - Variant
Type 2 Tyrosinemia (TAT deficiency) - Variant
Type 3 Tyrosinemia - Variant
VLCAD deficiency - Variant
VLCAD deficiency - Classical
CID requiring intervention
Syndrome with T-cell impairment
Syndrome with T-cell impairment \ 22q11.2 deletion syndrome
Syndrome with T-cell impairment \ CHARGE syndrome
Syndrome with T-cell impairment \ Ataxia telangiectasia
Syndrome with T-cell impairment \ Other, specify:
T-cell lymphopenia \ Idiopathic
T-cell lymphopenia \ Lymphangiectasia
T-cell lymphopenia \ Post thymectomy
T-cell lymphopenia \ Immunosuppressive medications, infant
T-cell lymphopenia \ Immunosuppressive medications, maternal
T-cell lymphopenia \ Medically unstable / perinatal stressors
T-cell lymphopenia \ Other, specify:
11-Beta Hydroxylase Deficiency
11-Beta Hydroxylase Deficiency - Variant
3-beta dehydrogenase deficiency - Variant
3-beta dehydrogenase deficiency
Beta and alpha globin variant(s)
Beta thalassemia (ex: beta0)
CF Indeterminate: borderline sweat (+/- genotype)
CF Indeterminate: genotype/normal sweat
CPTII (neonatal/infantile)
MCAD deficiency - Classical
MCAD deficiency - Variant
Persistent lab abnormalities
Pyridoxine responsive CBS deficiency
Pyridoxine responsive CBS deficiency - Variant
Cystathioninemia - Variant
Glycine N-Methyltransferase Deficiency - Variant
Methionine Adenosyltransferase Deficiency - Variant
S-Adenoslhomocysteine Hydrolase - Variant
SAM transferase deficiency - Variant
Citrullinemia (ASA synthetase deficiency) - Variant
ASA lysase deficiency - Variant
Citrullinemia Type II (Citrin deficiency) - Variant
Variant hemoglobin - no alpha/beta gene variants detected
SCID \ SCID- no identified mutation
CID requiring intervention \ ZAP70
CID requiring intervention \ RMRP
CID requiring intervention \ CID - no identified mutation
CID requiring intervention \ Other: Specify
|
NBS0018-02
|
Definitive diagnosis, other
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The diagnosis made in the infant / child (or mother) after investigations following a positive newborn screen when a definitive diagnosis is not available from the pick list.
|
NBS0018-03
|
Definitive diagnosis CH FIXED, other
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The specific reason that an infant with a positive newborn screen for congenital hypothyroidism was diagnosed with FIXED CH that is not athyrotic, ectopic, idiopathic, subclinical or related to dyshormonogenesis
|
NBS0018-04
|
Definitive diagnosis CH TRANSIENT, other
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The specific reason that an infant with a positive newborn screen for congenital hypothyroidism was diagnosed with TRANSIENT CH that is not athyrotic, ectopic, idiopathic, subclinical or related to dyshormonogenesis
|
NBS0030
|
Total Number of siblings of affected newborn screen positive child
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Total number of full siblings to the infant / child.
|
NBS0031
|
Total Number of affected siblings of affected newborn screen positive child
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Number of full siblings to the infant / child who are affected with the disease in question.
|
NBS0032
|
Other affected family members of affected newborn screen positive child
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Other family members of the infant / child who are affected with the disease in question. Specify relationship.
|
NBS0032-01
|
Affected family member, other
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The relationship of the affected family member to the newborn screen positive infant (DERF) or the affected infant (SDRF)
|
NBS0033
|
NSO Accession Number
|
Newborn Screening Ontario (NSO), NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Unique NSO identifier assigned at the time of NSO Accessioning.
|
NBS0038
|
Disposition after diagnostic evaluation and follow up
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
After clinical and / or diagnostic evaluations are completed, the decision to discharge, continue to follow without treatment or initiate treatment as indicated by regional treatment centre.
Pick List Value:
Continue to follow with no treatment
Refer to the Canadian Centre for Primary Immunodeficiency
|
NBS0038-01
|
Disposition rationale
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Comments regarding the disposition. If 'continue to follow without treatment' is selected, please specify reason(s) / rationale.
|
NBS0039
|
Date of Disposition
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Date disposition decision made
|
NBS0039-2
|
Disposition - Date treatment initiated (RTC)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Disposition - Date treatment initiated (RTC)
|
NBS0039-3
|
Disposition - Was treatment stopped (RTC)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Disposition - Was treatment stopped (RTC)
|
NBS0039-4
|
Disposition - Date treatment stopped (RTC)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Disposition - Date treatment stopped
|
NBS0039-5
|
Disposition - Was treatment ever initiated (CCPID)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Disposition - Was treatment ever initiated (CCPID)
|
NBS0039-6
|
Disposition - Date treatment initiated (CCPID)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Disposition - Date treatment initiated (CCPID)
|
NBS0039-7
|
Disposition - Was treatment stopped (CCPID)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Disposition - Was treatment stopped (CCPID)
|
NBS0039-8
|
Disposition - Date treatment stopped (CCPID)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Disposition - Date treatment stopped (CCPID)
|
NBS0041
|
Number of siblings of affected prior to diagnosis of newborn screen positive child
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Number of affected full siblings to the screen positive child who diagnosed prior to the current screen positive
|
NBS0042
|
Number of siblings of affected after diagnosis of newborn screen positive child
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Number of affected full siblings to the screen positive child who diagnosed after the current screen positive
|
NBS0043
|
Carrier Testing Offered
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Specify whether the baby's parents were offered carrier testing and the subsequent action
|
NBS0044
|
Carrier Testing Not Offered Reason
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Reason why the parents were not offered carrier testing
|
NBS0045
|
Carrier Testing Not Offered Reason - Other
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Specifics for why the parents were not offered carrier testing
|
NBS0108
|
Total Number of deceased sibs of affected newborn screen positive child
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Number of full siblings to the infant / child that are deceased.
|
NBS0109
|
Comments in regards to definitive diagnosis
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Comments regarding the newborn's definitive diagnosis made after a positive newborn screen (DERF) or regarding an infant affected with an NSO target disorder not ascertained by newborn screening (SDRF)
|
NBS0110
|
Diagnosis prior to retrieval of patient
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Indicates that the infant was diagnosed with the disease for which they screened positive prior to being retrieved for diagnostic evaluation
|
NBS0111
|
Health of screen positive infant at retrieval
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
What was the infant's health at the time they were located for diagnostic evaluation after a positive newborn screen
Pick List Value:
Deceased, specify date and cause
|
NBS0111-01
|
Unwell at retrieval
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The symptom(s) and / or reason(s) the screen positive infant was unwell at the time of retrieval
|
NBS0111-02
|
Date of death
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The date the infant / child died.
|
NBS0111-03
|
Cause of death
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The cause of death for the infant who had a positive newborn screen (DERF) or the infant affected with an NSO target disorder not ascertained by newborn screening (SDRF)
|
NBS0113
|
Newborn screen positive infant's name if different at diagnostic testing
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Newborn screen positive infant's name at diagnostic testing. Only captured if newborn's name is different than Newborn Name - Family Name (N0001)
|
NBS0114
|
Newborn screen positive infant's health care provider at diagnostic testing
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Newborn screen positive infant's primary health care provider at the time of retrieval and / or diagnostic testing.
|
NBS0120
|
Newborn Screen Positive Infant Symptomatic of (screen positive disease name)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
An indication of whether the infant had symptoms that could be attributed to the disease they were screen positive for at the time of retrieval
|
NBS0121
|
NSO Gaining Weight
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
An indication of whether an infant with a positive newborn screen was gaining weight at the time of retrieval for diagnostic evaluation
|
NBS0122
|
Newborn Screen Positive Infant Hospitalized due to (screen positive disease name)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
An indication of whether an infant with a positive newborn screen was hospitalized at the time of retrieval for diagnostic evaluation
|
NBS0123
|
NSO Meconium Ileus (CF)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
An indication of whether the infant with a newborn screen positive for cystic fibrosis was born with meconium ileus, noted at the time of retrieval for diagnostic evaluation
|
NBS0124
|
NSO Cough or Wheeze (CF)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
An indication of whether the infant with a newborn screen positive for cystic fibrosis had a cough or wheeze at the time of retrieval for diagnostic evaluation
|
NBS0125
|
Newborn Screen Positive Infant Virilised
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
An indication of whether the infant with a newborn screen positive for congenital adrenal hyperplasia was virilised at birth, noted at the time of retrieval for diagnostic evaluation
|
NBS0126
|
NSO Maternal Steroids
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
An indication of whether the mother of an infant with a newborn screen positive for congenital adrenal hyperplasia was given steroids at any time during her pregnancy, noted at the time of retrieval for diagnostic evaluation
|
NBS0127
|
DERF completed by
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The name of the regional treatment centre health care professional who completed the newborn screen positive infant's DERF / SDRF
Pick List Value:
ALABDOULSALAM, DR. TAREQ (Children's Hospital of Winnipeg)
ANDRIGHETTI, HEATHER (Hamilton Health Sciences)
ATHALE, DR. UMA (Hamilton Health Sciences Centre)
BABIC, DR. BOJANA (Hamilton Health Sciences Centre)
BELANGER, BRIGITTE (Children's Hospital of Eastern Ontario)
BELEGRIS, CATHY ((London Health Sciences Centre - Pediatric Endocrinology)
BELL, SHANNON (Kingston Health Sciences Centre)
BENOIT, CAROLINE (Children’s Hospital of Eastern Ontario)
BERES, LORRIE - GC (Hamilton Health Sciences Centre)
BOILEAU, CORALEE (CHILDREN'S HOSPITAL OF EASTERN ONTARIO)
BOLAND, DR. MARGARET PATRICIA (Children's Hospital of Eastern Ontario)
BRAGER, RAE (Hamilton Health Sciences)
BRICK, LAUREN - GC (Hamilton Health Sciences Centre)
CARPENTER, REBECCA (McMaster Children's Hospital)
CHAGNON, JULIA (McMaster Children's Hospital)
CHAKRABORTY, DR. PRANESH (Children's Hospital of Eastern Ontario)
CLARSON, DR. CHERIL LINDA (London Health Sciences Centre - Endocrinology)
COLAICOVO, SAMANTHA (London Health Sciences Centre - Genetics)
COOK, CINDY (Children’s Hospital of Eastern Ontario)
COSTANTINI, SHARON (Children’s Hospital of Eastern Ontario)
COWING, GINA (McMaster Children's Hospital)
CRUZ, Vivian (Hospital for Sick Children)
DALE, BREANNE (Hamilton Health Sciences Centre)
DAVIES, CHRISTINE - GC (Children's Hospital of Eastern Ontario)
DIRAIMO, JENNIFER (London Health Sciences Centre - Genetics)
DUFFY, LAURA (McMaster Children's Hospital)
FERNANDEZ, SARA (Children's Hospital of Eastern Ontario)
FRASER, Meghan (Hospital for Sick Children)
GALL, KIM - GC (Children's Hospital of Eastern Ontario)
GALLAGHER, LAUREN (Children's Hospital of Eastern Ontario)
GALLEGO, DR. P (London Health Sciences Centre - Endocrinology)
GERAGHTY, DR. MICHAEL (Children's Hospital of Eastern Ontario)
GIGNAC, MARIEVE (Children's Hospital Of Eastern Ontario)
GLODEANU, MIHAELA (Children's Hospital of Eastern Ontario)
GOOBIE, DR. SHARAN LYNN (London Health Sciences Centre - Genetics)
GRASEMANN, HARTMUT (Hospital for Sick Children)
GUILDER, DR. LAURA (Hospital for Sick Children)
HADJIYANNAKIS, DR. ANASTASIA (Children's Hospital of Eastern Ontario)
HAYLOR, JANA (London Health Sciences Centre)
HAMILTON, DR. JILL KRYSTI (Hospital for Sick Children)
HEWSON, STACY (Hospital for Sick Children)
HO, STEPHANIE (London Health Sciences Centre - Genetics)
JARDINE, DR. Lawrence (London Health Sciences Centre - Genetics)
JOHNSON, KIRSTI (Hospital for Sick Children)
KIRBY, DR. MELANIE-ANN (Hospital for Sick Children)
KLAASSEN, DR. ROBERT JOHN (Children's Hospital of Eastern Ontario)
KOVESI, DR. THOMAS ANDREW (Children's Hospital of Eastern Ontario)
KOZENKO, DR. MARIYA (Hamilton Health Sciences Centre)
KRONICK, DR. JONATHAN (Metabolics)
LAM, DR. CAROL (Hospital for Sick Children)
LANGDON, KRISTEN (London Health Sciences Centre)
ROADHOUSE, CHELSEA (Hamilton Health Sciences Centre)
LAWRENCE, DR. SARAH ELIZABETH (Children's Hospital of Eastern Ontario)
WATTS-DICKENS, ABBY (Hospital for Sick Children)
LEPPINGTON, SARAH (Children's Hospital of Western Ontario)
LESCADRE, TAMMY ((London Health Sciences Centre - Pediatric Endocrinology)
LI, DR. CHUMEI (Hamilton Health Sciences Centre)
LOCKYER, LINDSAY (The Hospital for Sick Children)
LOOMER-VANDERSLUIS, MADELINE (Hamilton Health Sciences Centre)
MACKENZIE, DR. JENNIFER JANE (Kingston General Hospital)
Mahin, Vanessa (London Health Sciences Centre)
MAHMUD, DR. FARID HUSSAIN (Hospital for Sick Children)
MAHMUTOGLU, DR. SAADET (Metabolics)
MARCADIER, JANET - GC (Children's Hospital of Eastern Ontario)
McASSEY, DR. KAREN LYNN (Hamilton Health Sciences Centre)
MCNIVEN, DR. VANDA (Hamilton Health Sciences Centre)
MCGREGOR, ANGELA (Kingston)
McSHANE, HOLLY (RN - Hotel Dieu Hospital)
MHANNI, DR AZIZ (WRHA Genetics & Metabolism Program)
MORAR, OANA (London Health Sciences Centre - Genetics)
NAPIER, MELANIE (London Health Sciences Centre - Genetics)
NORI, KELLY (Hamilton Health Sciences Centre)
NOWACZYK, DR. MALGORZATA JOANNA (Hamilton Health Sciences Centre)
ODAME, DR. ISAAC (Hospital for Sick Children)
MUCHANTEF, KIM (Children’s Hospital of Eastern Ontario)
PALMERT, DR. MARK RANEY (Hospital for Sick Children)
PARADISO, CHRISTINA - GC (Hamilton Health Sciences Centre)
PASTERKAMP, DR. HANS (CHILDREN'S HOSPITAL OF WINNIPEG)
PEDDER, DR. LINDA (Hamilton Health Sciences Centre)
PEREIRA, MYRA (Hospital for Sick Kids)
PERLMAN, DR. KUSIEL (Hospital for Sick Children)
PIRES, LINDA (Canadian Centre for Primary Immunodeficiency)
POTTER, DR. MURRAY ALEXANDER (Hamilton Health Sciences Centre)
PRASAD, DR. CHITRA (London Health Sciences Centre - Genetics)
PRICE, DR. APRIL KATHERINE (London Health Sciences Centre - Genetics)
RAIMAN, DR. JULIAN ANDREW JONATHON (Hospital for Sick Children)
RATJEN, DR. FELIX ALEXANDER (Hospital for Sick Children)
REID, BRENDA (Canadian Centre for Primary Immunodeficiency)
ROCKMAN-GREENBERG, DR. CHERYL (WRHA Genetics & Metabolism Program)
RYBANSKY, SUSAN (London Health Sciences Centre - Genetics)
SALEH, DR.DAVID (Kingston General Hospital)
SAMAAN, DR. CONSTANTINE (Hamilton Health Sciences Centre)
ROBART, SARAH (Hospital for Sick Children)
SCHULZE, DR. ANDREAS (Hospital for Sick Children)
SHAVER, JENNIFER (Kingston General Hospital)
SHURRAB, DR. SHAYMAA (McMaster Children's Hospital)
SILVA, DR. MARIANA (Kingston General Hospital)
SIRIWARDENA, DR. KOMUDI PULSARA (Hospital for Sick Children)
SOCHETT, ETIENNE (Hospital for Sick Children)
SOLOMON, MELINDA (Hospital for Sick Children)
SOTTOSANTI, DR. M (London Health Sciences Centre - Endocrinology)
STEIN, DR. ROBERT IAN (London Health Sciences Centre - Endocrinology)
SVELA, YULIA (Hospital for Sick Children)
TAM, KAREN (Hospital for Sick Children)
TAZBAZ, TANYA - RN (Hospital for Sick Children)
Thibert, Anna(WRHA Respirology)
URBACH, DR. STACEY LISA (Hospital for Sick Children)
VAN WYLICK, DR. RICHARD CECIL (Kingston General Hospital)
VANDERMEULEN, DR. JOHN AUGUST (Hamilton Health Sciences Centre)
WAGLER, STEOHANIE - GC (Hamilton Health Sciences Centre)
WASSERMAN, DR. JONATHAN (Metabolics)
WHERRETT, DR. DIANE KATHERINE (Hospital for Sick Children)
ZELENIETZ, SARI - GC (Children's Hospital of Eastern Ontario)
Zingerat, Sharri-Lynne (Sudbury CF Clinic)
TELLIER, ISABELLE (CHU St Justine)
LEVASSEUR, MICHELE (Children’s Hospital of Eastern Ontario)
BRUNEL-GUITTON, DR.CATHARINE (CHE Sainte Justine, Medical Genetics)
MAZUR, Katherine (Hamilton Health Sciences)
Mol, Jarmila RN ( Hospital for Sick Children)
Brittney Johnstone (Hospital for Sick Children)
Sabrina Bhathal (Hospital for Sick Children)
ANDRIGHETTI, HEATHER (London Health Sciences Centre)
Quann, Stephanie (Kingston Health Sciences Centre)
YANG, NICOLE (The Hospital for Sick Children)
|
NBS0128
|
Date DERF completed
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The date on which the DERF or SDRF was confirmed to be submitted to BORN by the regional treatment centre. This data element is derived based on the date the DERF / SDRF is confirmed to be submitted to BORN.
|
NBS0129
|
Regional Treatment Centre Responsible Physician
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
The name of the physician at the Regional Treatment Centre who was / is responsible for the care of the infant / child
Pick List Value:
ALABDOULSALAM, DR. TAREQ (Children's Hospital of Winnipeg)
ALJOUDA, DR. LIALI (Hospital for Sick Children)
ATHALE, DR. UMA (Hamilton Health Sciences Centre)
BABALOLA, DR. FUNMBI (London Health Sciences Centre)
BABIC, DR. BOJANA (Hamilton Health Sciences Centre)
Brager, Dr.Rae HHSC paediatric immunologist
BOLAND, DR. MARGARET PATRICIA (Children's Hospital of Eastern Ontario)
CHAKRABORTY, DR. PRANESH (Children's Hospital of Eastern Ontario)
CLARSON, DR. CHERIL LINDA (London Health Sciences Centre - Endocrinology)
Derynck, DR. Michael (Kingston Health Sciences Centre - Pediatric Respirologist)
DUA, DR. MEAGHNA (McMaster Children's Hospital)
Ejaz, Dr. Resham(Hamilton Health Sciences Centre)
EJAZ, DR. RESHAM (McMaster Children's Hospital)
ENS, DR. ANDREA (London Health Sciences Centre)
GALLEGO, DR. P (London Health Sciences Centre - Endocrinology)
GEDDIE, DR. HANNAH (McMaster Children's Hospital)
GEERLINKS, DR. ASHLEY (London Health Sciences Center)
GERAGHTY, DR. MICHAEL (Children's Hospital of Eastern Ontario)
GOOBIE, DR. SHARAN LYNN (London Health Sciences Centre - Genetics)
GRAKABY, DR. JENNY (McMaster Children's Hospital)
GRASEMANN, HARTMUT (Hospital for Sick Children)
GUILDER, DR. Laura (Hospital for Sick Children)
HADJIYANNAKIS, DR. ANASTASIA (Children's Hospital of Eastern Ontario)
HAMILTON, DR. JILL KRYSTI (Hospital for Sick Children)
INBAR-FEIGENBERG, DR. MICHAL (Hospital for Sick Children)
JARDINE, DR. Lawrence (London Health Sciences Centre - Genetics)
JUSKEY, LIA (Hospital for Sick Children)
Julia Catherine, Dr. Sorbara (The Hospital for Sick Children)
Karp, Dr. Natalya (London Health Sciences Center
Khatchadourian, Dr. Karine (Children's Hospital of Eastern Ontario)
KIRBY, DR. MELANIE-ANN (Hospital for Sick Children)
KLAASSEN, DR. ROBERT JOHN (Children's Hospital of Eastern Ontario)
KOVESI, DR. THOMAS ANDREW (Children's Hospital of Eastern Ontario)
KOZENKO, DR. MARIYA (Hamilton Health Sciences Centre)
KRONICK, DR. JONATHAN (Hospital for Sick Children)
LAM, DR. CAROL (Hospital for Sick Children)
LAPIERRE, DR. JEAN GUY (CHU St Justine)
LAWRENCE, DR. SARAH ELIZABETH (Children's Hospital of Eastern Ontario)
LI, DR. CHUMEI (Hamilton Health Sciences Centre)
MACKENZIE, DR. JENNIFER JANE (Kingston General Hospital)
MACKENZIE, DR. JENNIFER (Hamilton Health Sciences Centre)
MAHMUD, DR. FARID HUSSAIN (Hospital for Sick Children)
MAHMUTOGLU, DR. SAADET (Hospital for Sick Children)
McASSEY, DR. KAREN LYNN (Hamilton Health Sciences Centre)
MCNIVEN, DR. VANDA (Hamilton Health Sciences Centre)
MHANNI, DR AZIZ (WRHA Genetics & Metabolism Program)
NASR, DR ENAS (London Health Science Center - Genetics)
NORDLUND, DR SAMANTHA (McMaster Children's Hospital)
NOWACZYK, DR. MALGORZATA JOANNA (Hamilton Health Sciences Centre)
ODAME, DR. ISAAC (Hospital for Sick Children)
OEI, DR. KRISTA (Hospital for Sick Children)
PALMERT, DR. MARK RANEY (Hospital for Sick Children)
PASTERKAMP, DR. HANS (CHILDREN'S HOSPITAL OF WINNIPEG)
PEDDER, DR. LINDA (Hamilton Health Sciences Centre)
PERLMAN, DR. KUSIEL (Hospital for Sick Children)
PHAM-HUY, DR. ANNE (CHEO Infectious Diseases)
POTTER, DR. MURRAY ALEXANDER (Hamilton Health Sciences Centre)
PRASAD, DR. CHITRA (London Health Sciences Centre - Genetics)
PRICE, DR. APRIL KATHERINE (London Health Sciences Centre - Genetics)
RAIMAN, DR. JULIAN ANDREW JONATHON (Hospital for Sick Children)
RATJEN, DR. FELIX ALEXANDER (Hospital for Sick Children)
SALEH, DR. MAHA (London Health Sciences Centre)
SETHNA, DR MIA (London Health Science Center - Genetics)
ROCKMAN-GREENBERG, DR. CHERYL (WRHA Genetics & Metabolism Program)
SALEH, DR.DAVID (Kingston General Hospital)
SAMAAN, DR. CONSTANTINE (Hamilton Health Sciences Centre)
SCHULZE, DR. ANDREAS (Hospital for Sick Children)
SHURRAB, DR. SHAYMAA(McMaster Children's Hospital)
SILVA, DR. MARIANA (Kingston General Hospital)
SIRIWARDENA, DR. KOMUDI PULSARA (Hospital for Sick Children)
SOCHETT, ETIENNE (Hospital for Sick Children)
SOLOMON, MELINDA (Hospital for Sick Children)
SOTTOSANTI, DR. M (London Health Sciences Centre - Endocrinology)
Soumitra , Dr. Tole, (London Health Sciences Centre)
STEIN, DR. ROBERT IAN (London Health Sciences Centre - Endocrinology)
TENEDERO, DR CHRISTINE (McMaster Children's Hospital
URBACH, DR. STACEY LISA (Hospital for Sick Children)
VAN WYLICK, DR. RICHARD CECIL (Kingston General Hospital)
VANDERMEULEN, DR. JOHN AUGUST (Hamilton Health Sciences Centre)
WASSERMAN, DR. JONATHAN (Hospital for Sick Children)
WHERRETT, DR. DIANE KATHERINE (Hospital for Sick Children)
BASSILIOUS, DR. ERENY (McMaster Children's Hospital)
SIMPSON, EWURABENA (Children’s Hospital of Eastern Ontario)
REISMAN, JOE (Children’s Hospital of Eastern Ontario)
BERUBE, DR. DENIS (CHU St Justine)
FROSK, DR. PATRICK (WRHA Genetics & Metabolism Program)
Iqbal, Shaikh Mohammed (Children’s Hospital of Winnipeg)
WALIA, DR.JAGDEEP (Kingston General Hospital)
Kumar, Dr. Gautam (Sudbury CF Clinic)
Al-Somali, Dr. Faisal (WRHA Respirology)
Marcotte, Dr. Jacques (CHU St Justine)
BRUNEL-GUITTON, DR.CATHARINE (CHE Sainte Justine, Medical Genetics)
Guerin, Dr.Andrea (Kingston General Hosptial)
COHN, Dr. RONALD (The Hospital for Sick Children)
Sondheimer, Dr. Neal (The Hospital for Sick Children)
Rusnak, Dr. Allison (Kingston General Hospital)
HARRINGTON, DR. JENNIFER JEAN (Hospital for Sick Children)
SHULMAN, DR. RAYZEL MALKA (Hospital for Sick Children)
Badalato, Dr. Lauren ( Kingston Health Sciences Centre)
YU, Dr. ANDREA C (Children's Hospital of Eastern Ontario)
Wheaton, Dr. Laura (Kingston Health Sciences Centre)
BOURQUE, DR. DANIELLE (Children's Hospital of Eastern Ontario)
|
NBS0134
|
NSO STFU Follow-Up Diagnostic Analyte Unit of Measure
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The unit of measure of the diagnostic analyte or profile analytes
|
NBS0135
|
NSO STFU Follow-Up Diagnostic Analyte Ref Range Upper
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The upper limit of the reference range for the diagnostic analyte or profile analytes
|
NBS0136
|
NSO STFU Follow-Up Diagnostic Analyte Ref Range Lower
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The lower limit of the reference range for the diagnostic analyte or profile analytes
|
NBS0137
|
NSO STFU Follow-Up Profile Date
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The date on which the diagnostic evaluations and investigations were performed
|
NBS0138
|
NSO STFU Follow-Up Profile Comment
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Comments regarding the diagnostic investigations and / or evaluations
|
NBS0139
|
Age of Symptom Onset
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Age of symptom onset
|
NBS0140
|
NSO Treatment Initiated (RTC)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Treatment initiated on the infant after the diagnosis (RTC)
|
NBS0140CCPID
|
NSO Treatment Initiated (CCPID)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Treatment initiated on the infant after the diagnosis (CCPID)
|
NBS0141
|
NSO Treatment Initiated - Other (RTC)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Other treatment initiated on the infant after the diagnosis.
|
NBS0141CCPID
|
NSO Treatment Initiated - Other (CCPID)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Other treatment initiated on the infant after the diagnosis (CCPID)
|
NBS0142
|
NSO Diagnosis Made Prenatally Flag
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Indicates if the diagnosis was made prenatally or postnatally.
|
NBS0143
|
Diagnosis Made Outside of Regional Treatment Centre Flag
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Indicates if the diagnoses was made outside of a Regional Treatment Centre. If so, please enter the SRDF Completed by and Responsible Physician boxes.
|
NBS0145
|
Biopterin Response Comment
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Biopterin Response Comment
|
NDERF0123
|
Reason infant not retrieved
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Indicates the reason(s) that an infant has not been retrieved at the time Retrieval Confirmation Information is submitted to BORN
Pick List Value:
Awaiting call back from parents
Incorrect contact information
No contact information for primary health care provider
Phone number out of service
Awaiting call back from primary health care provider
Unable to contact health care provider
Transferred to another treatment centre
Incorrect health care provider listed
No voice mail to leave message
Registered mail undeliverable
CAS involved to help locate
Family / parents out of country
No health care provider indicated
Parents contacted directly
No contact information for family
|
NDERF0123O
|
Reason infant not retrieved - Other
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The reason that an infant has not been retrieved at the time Retrieval Confirmation Information is submitted to BORN not represented in the pick list.
|
NDERF02324
|
No follow up diagnostic testing initiated
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Indicates that no diagnostic testing was initiated in follow up to a infant / child's referral to a Regional Treatment Centre from Newborn Screening Ontario
Pick List Value:
After clinical evaluation by specialist physician completed, diagnostic testing deemed unnecessary
Parents declined – previous child had a positive screen and normal diagnostic testing
Parents declined – current child had a negative screen in addition to a positive screen
|
NDERF02324OTHER
|
No follow up diagnostic testing initiated Other
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
An indication that the reason that no follow up diagnostic testing was initiated is not captured by the values presented in the pick list
|
NDERF02325
|
Screen Positive Comments
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
|
NDERF4512
|
Initial Diagnosis
|
NSO Diagnostic Evaluation Report Form (DERF)
|
Data Definition:
Diagnosis based on initial diagnostic investigations
|
NDERF4513
|
Date of Initial Diagnosis
|
NSO Diagnostic Evaluation Report Form (DERF)
|
Data Definition:
Date an initial diagnosis is made
|
NDERFANALYG
|
Analyte Gene
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The gene that was interrogated as part of the infant / child's diagnostic investigations
Pick List Value:
ADA (Adenosine Deaminase Deficiency)
PNP (Purine nucleoside phosphorylase deficiency)
AK2 (SCID with leukopenia)
RAC2 (neutrophil deficiency syndrome)
PTPRC (PTPRC-related SCID)
ZAP70 (ZAP70-related SCID)
RMRP (Cartilage-Hair hypoplasia)
ACADM (Medium-chain acyl-CoA dehydrogenase)
ACADVL (Very long chain acyl-CoA dehydrogenase)
ACAT1 (acetoacetyl 1-Co A-thiolase)
AHCY (S-adenosylhomocysteine hydrolase)
ASL (Argininosuccinate lyase)
ASS1 (Argininosuccinate synthetase)
AUH (AU RNA binding protein/enoyl-Coenzyme A hydratase)
BCKDHA (Branched chain keto acid dehydrogenase E1, alpha polypeptide)
BCKDHB (Branched chain keto acid dehydrogenase E1, beta polypeptide)
CBS (Cystathionine beta synthase)
CFTR (Cystic fibrosis transmembrane conductance regulator, ATP-binding cassette (sub-family C, member 7) ABCC7)
CPT1A (Carnitine Palmitoyltransferase I, liver)
CPT2 (Carnitine Palmitoyltransferase 2)
CTH (Cystathionase (cystathionine gamma-lyase) )
CYP21A2 (Cytochrome P450, subfamily XXIA (steroid 21-hydroxylase, congenital adrenal hyperplasia), polypeptide 2)
DBT (Dihydrolipoamide branched chain transacylase E2)
DLD (Dihydrolipoamide Dehydrogenase)
DNAJC19 (Dnaj (hsp40) homologue, subfamily c, member 19)
ETFA (Electron-transfer-flavoprotein, alpha polypeptide)
ETFB (Electron-transfer-flavoprotein, beta polypeptide)
ETFDH (Electron-transferring-flavoprotein dehydrogenase)
FAH (fumarylacetoacetate hydrolase (fumarylacetoacetase) )
GALT (Galactose-1-phosphate uridyl transferase)
GCDH (Glutaryl-CoA Dehydrogenase)
GCH1 (GTP Cyclohydrolase I)
GNMT (Glycine N-methyltransferase)
HADHA (Mitochondrial trifunctional protein, alpha subunit)
HADHB (Mitochondrial trifunctional protein, beta subunit)
HBA2 (hemoglobin, alpha-2)
HLCS (Holocarboxylase synthetase)
HMGCL (3-hydroxymethyl-3-methylglutaryl-CoA lyase)
HPD (4-hydroxyphenylpyruvate dioxygenase)
HSD17B10 (hydroxysteroid (17-beta) dehydrogenase 10)
IVD (Isovaleryl-CoA dehydrogenase)
IYD (Iodotyrosine deiodinase)
MAT1A (Methionine adenosyltransferase I, alpha)
MCCC1 (Methylcrotonoyl-coenzyme A carboxylase 1 (alpha) )
MCCC2 (Methylcrotonoyl-coenzyme A carboxylase 2 (beta) )
MMAA (Methylmalonic aciduria (cobalamin deficiency) type A)
MMAB (Methylmalonic aciduria (Cobalamin deficiency) type B)
MMACHC (Methylmalonic aciduria (cobalamin deficiency) cblC type)
MMADHC (methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria)
MUT (Methylmalonyl CoA mutase)
OPA3 (Optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) )
PAH (Phenylalanine hydroxylase)
PAX8 (Paired box homeotic gene 8)
PCBD1 (Pterin-4-alpha-carbinolamine dehydratase 1)
PCCA (propionyl CoA carboxylase, alpha polypeptide)
PCCB (propionyl CoA carboxylase, beta polypeptide)
PTS (6-pyruvoyltetrahydropterin synthase)
QDPR (Quinoid dihydropteridine reductase)
SLC22A5 (Solute carrier family 22 (organic cation transporter), member 5 (OCTN2) )
SLC25A13 (Solute carrier family 25, member 13 (Citrin))
SPR (sepiapterin reductase)
TAT (Tyrosine aminotransferase)
TAZ (Tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2 - Barth syndrome))
TSHR (Thyroid stimulating hormone receptor)
|
NDERFCCPID
|
DERF is CCPID flag
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
DERF is CCPID flag
|
NDERFCMPL
|
If the DERF and review process complete?
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Indicates whether the DERF / SDRF and the NSO review process of the DERF / SDRF are complete. This field is to be completed by NSO users only.
|
NDERFDDINF
|
Was the diagnosis made in the infant?
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
An indication of whether the definitive diagnosis was made in the infant.
|
NDERFDDMOTH
|
Was the diagnosis made in the mother?
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
An indication of whether the definitive diagnosis was made in the mother.
|
NDERFFRM1
|
Date Retrieval Confirmation Form Submitted to NSO
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The date that the Retrieval Confirmation Information was saved in the BORN system
|
NDERFFRMTYPE
|
NSO DERF Form Type
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Indicates the disease specific Diagnostic Evaluation Report Form
Pick List Value:
Congenital Adrenal Hyperplasia (CAH)
Congenital Hypothyroidism (CH)
Isovaleric Acidemia (IVA)
Maple Syrup Urine Disease (MSUD)
Severe Combined Immunodeficiency (SCID)
|
NDERFFVISR
|
DERF Follow-Up Visit Required Flag
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
DERF Follow-Up Visit Required Flag
|
NDERFGENEVAR
|
NSODERF Gene Variant
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
NSODERF Gene Variant
Pick List Value:
c.1001A>G (p.Lys334Arg; p.K334R)
c.1009_1011del (p.Leu337del)
c.100G>A (p.Gly34Ser; p.G34S)
c.1010A>C (p.Tyr337Ser; p.Y337S)
c.1016C>T (p.Ser339Leu; p.S339L)
c.1027G>C (p.Gly343Arg; p.G343R)
c.1040G>C (p.Arg347Pro; p.R347P)
c.1045C>T (p.Arg349Ter; p.R349X)
c.1046C>T (p.Ala349Val; p.A349V)
c.1049 C>A (p.Ser350Tyr; p.S350Y)
c.105_109del (p.Arg37Alafs*20)
c.1052delC (p.Thr351Lysfs*12; p.T351Kfs*12)
c.1115C>A (p.Ala372Asp; p.A372D)
c.1135G>A (p.Ala379Thr; p.A379T)
c.1148T>A (p.Phe383Tyr; p.F383Y)
c.1168G>A (p.Gly390Arg; p.G390R)
c.1169A>G (p.Glu390Gly; p.E390G)
c.1171C>T (p.Pro391Ser; p.P391S)
c.1173C>A (p.Phe391Leu; p.F391L)
c.1193C>A (p.Ala398Asp; p.A398D)
c.1208C>T (p.Ala403Val; p.A403V)
c.1213A>G (p.Met405Val; p.M405V)
c.1222C>T (p.Arg408Trp; p.R408W)
c.1241A>G (p.Tyr414Cys; p.Y414C)
c.1247T>C (p.Ile416Thr; p.I416T)
c.1253G>A (p.Ser418Asn; p.S418N)
c.1312T>A (p.Tyr438Asn; p.Y438N)
c.1322G>A (p.Gly441Asp; p.G441D)
c.1324G>T (p.Val442Phe; p.V442F)
c.133G>A (p.Gly45Arg; p.G45R)
c.1348T>G (p.Trp450Gly; p.W450G)
c.1360G>A (p.Asp454Asn; p.D454N)
c.1361A>G (p.Tyr454Cys; p.Y454C)
c.1363delC (p.Leu455Phefs)
c.1367G>A (p.Arg456His; p.R456H)
c.1375dupC (p.Arg459Profs)
c.1376G>A (p.Arg459Gln; p.R459Q)
c.1388G>A (p.Gly463Glu; p.G463E)
c.1408A>G (p.Met470Val; M470V)
c.142G>C (p.Asp48His; Hb Hasharon)
c.143T>C (p.Leu48Ser; p.L48S)
c.1451_1452delGGinsC (p.Arg484Profs)
c.1451A>G (p.His484Arg; p.H484R)
c.1475A>C (p.Asp492Ala; p.D492A)
c.1475C>T (p.Thr492Ile; p.T492I)
c.1489C>T (p.Pro497Ser; p.P497S)
c.1500_1502del (p.Leu502del)
c.151C>T (p.His51Tyr; p.H51Y)
c.1528G>C (p.Glu510Gln; p.E510Q)
c.157C>T (p.Arg53Cys; p.R53C)
c.157G>A (p.Asp53Asn; Hb Osu Christiansborg)
c.1584G>A (p.Glu528Glu; p.E528E)
c.1603C>G (p.Leu535Val; p.L535V)
c.1612C>T (p.Arg538Cys; p.R538C)
c.1616A>G (p.Gln539Arg; p.Q539R)
c.1700G>A (p.Arg567Gln; p.R567Q)
c.-170G>A (Sardinian HPFH)
c.1727G>C (p.Gly576Ala; p.G576A)
c.1741G>T (p.Val581Phe; p.V581F)
c.1793A>G (p.His598Arg; p.H598R)
c.1844G>A (p.Arg615Gln; p.R615Q)
c.1868G>T (p.Gly623Val; p.G623V)
c.194T>C (p.Ile65Thr; p.I65T)
c.19G>A (p.Asp7Asn; Hb Dunn)
c.1A>G (p.Met1Val; p.M1V)
c.2002C>T (p.Arg668Cys; p.R668C)
c.200C>T (p.Thr67Met; p.T67M)
c.2015_2052delAAinsG (p.Lys684SerfsX38; 2183AA>G)
c.209C>T (p.Ser70Leu; p.S70L)
c.224G>A (p.Arg75Gln; R75Q)
c.2260G>A (p.Val754Met; V754M)
c.227T>C (p.Ile76Thr; Hb F Waynesboro)
c.227T>C (p.Leu76Pro; Hb Atlanta)
c.233T>C (p.Ile78Thr; p.I78T)
c.236G>A (p.Arg79His; p.R79H)
c.253G>T (p.Gly85Cys; p.G85C)
c.2562T>G (p.Thr854Thr; 2694T>G)
c.262_264delGAG (p.Glu88del; p.E88del)
c.276G>T (p.Glu92Asp; p.E92D)
c.281 A>G (p.Asp94Gly; p.D94G)
c.283G>A (p.Asp95Asn; Hb F Columbus-GA)
c.287G>T (p.Gly96Val; p.G96V)
c.290A>T (p. Asp97Val; p.D97V)
c.3067_3072delTAGTG (p.Ile1023Serfs)
c.3196C>T (p.Arg1066Cys; p.R1066C)
c.3197G>A (p.Arg1066His; p.R1066H)
c.3222T>A (p.Phe1074Leu; p.F1074L)
c.332_339delGAGACTAC (p.Gly111Valfs)
c.349C>T (p.Arg117Cys; p.R117C)
c.34G>A (p.Ala12Thr; p.A12T)
c.362C>T (p.Thr121Ile; p.T121I)
c.366T>G (p.Asn122Lys; p.D122K)
c.372T>A (p.Asp142Glu; p.D142E)
c.377G>A (p.Gly126Asp; p.G126D)
c.3794G>T (p.Gly1265Val; p.G1265V)
c.380C>T (p.Pro127Leu; p.P127L)
c.382_384delTAC (p.Tyr128del)
c.383_385del (p.Val128del)
c.3846G>A (p.Trp1282Ter; W1282X)
c.3889dupT(p.Ser1297Phefs*5)
c.3905T>C (p.Met1302Thr; p.M1302T)
c.394C>T (p.Arg132Stop; p.R132X)
c.397G>T (p.Val133Leu; p.V133L)
c.4272C>T (p.Tyr1424Tyr; p.Y1424Y)
c.428A>G (p.Asp143Gly; p.D143G)
c.436C>T (p.Arg146Trp; pR146W)
c.437delT (p.Leu146Trpfs)
c.4389G>A (p.Gln1463Gln; p.Q1463Q)
c.43G>T (p.Gly15Trp; p.G15W)
c.44 T>C (p.Val5Ala; p.V5A)
c.442delA (p.Ile148Leufs)
c.443A>G (p.Gln148Arg; p.Q148R)
c.443C>T (p.Thr148Ile; p.T148I)
c.443G>A (p.Arg148Lys; p.R148K)
c.443T>C (p.Ile148Asn; p.I148N)
c.470G>A (p.Arg157His; p.R157H)
c.473G>A (p.Arg158Gln; p.R158Q)
c.507delG (p.Glu169AspfsX11)
c.50G>A (p.Gly17Asp; Hb J-Baltimore)
c.511G>A (p.Ala171Thr; p.A171T)
c.518T>A (p.Ile173Asn; p.I173N)
c.51C>G (p.Phe17Leu; p.F17L)
c.535G>T (p.Gly179Trp; p.G179W)
c.547C>T (p.Arg183Trp; p.R183W)
c.556C>T (p.Arg186Trp; p.R186W)
c.556C>T (p.His186Tyr; p.H186Y)
c.557G>A (p.Cys186Tyr; p.C186Y)
c.56_57delGCinsAA (p.Arg19Gln; p.R19Q)
c.568C>T (p.His190Tyr; p.H190Y)
c.572T>C (p.Met191Thr; p.M191T)
c.575T>G (p.Phe192Cys; p.F192C)
c.577C>T (p.Arg193Trp; p.R193W)
c.604T>C (p.Phe202Leu; p.F202L)
c.629A>G (p.Tyr210Cys; p.Y210C)
c.631C>T (p.Arg211Cys; p.R211C)
c.632G>A (p.Arg211His; p.R211H)
c.638T>C (p.Leu213Pro; p.L213P)
c.641A>C (p.Asn214Thr; p.N214T)
c.641A>G (p.Asn214Ser; p.N214S)
c.641T>A (p.Ile214Lys; p.I214K)
c.645C>T (p.Leu215Leu; p.L215L)
c.64C>T (p.Pro22Ser; p.P22S)
c.652C>T (p.Leu218Leu; p.L218L)
c.656G>A (p.Arg219His; p.R219H)
c.658_660delAAG (p.Lys220del)
c.680A>T (p.Asp227Val; p.D227V)
c.682G>T (p.Asp228Tyr; D228Y)
c.683A>G (p.Asn228Ser; p.N228S)
c.701C>T (p.Thr234Ile; p.T234I)
c.701G>A (p.Arg234Gln; p.R234Q)
c.709G>A (p.Ala237Thr; p.A237T)
c.710T>A (p.Ile237Asn; p.I237N)
c.713T>A (p.Val238Glu; p.V238E)
c.719T>A (p.Met240Lys; p.M240K)
c.722G>A (p.Arg241His; p.R241H)
c.728G>A (p.Arg243Gln; p.R243Q)
c.734T>C (p.Val245Ala; p.V245A)
c.757G>A (p.Asp253Asn; p.D253N)
c.775C>T (p.Arg259Trp; p.R259W)
c.779C>T (p.Thr260Met; p.T260M)
c.782G>A (p.Arg261Gln; R261Q)
c.787G>A (p.Val263Met; p.V263M)
c.855G>T (p.Lys285Asn; p.K285N)
c.8591A>C (p.His2864Pro; p.H2864P)
c.860G>A (p.Gly287Asp; p.G287D)
c.865G>A (p.Gly289Arg; p.G289R)
c.877G>A (p.Ala293Thr; p.A293T)
c.881G>A (p.Gly294Glu; p.G294E)
SNP rs150422765 (intron variant)
c.887_888delCT (p.Pro296Argfs)
c.887G>A (p.Arg296Gln; p.R296Q)
c.895C>T (p.Arg299Cys; p.R299C)
c.896_898delAGA (p.Lys299del)
c.896A>T (p.Lys299Met; p.K299M)
c.896C>T (p.Ala299Val; p.A299V)
c.896T>G (p.Phe299Cys; p.F299C)
c.898G>T (p.Ala300Ser; p.A300S)
c.916A>G (p.Ile306Val; p.I306V)
c.923dupT (p.Leu308Phefs)
c.925G>A (p.Gly309Arg; p.G309R)
c.92C>T (p.Pro31Leu; p.P31L)
c.92G>C (p.Arg31Thr; Hb Kairouan)
c.937C>T (p.Arg313Trp; p.R313W)
c.939A>G (p.Ile313Met; p.I313M)
c.950T>C (p.Val317Ala; p.V317A)
c.956C>T (p.Ser319Phe; p.S319F)
c.958T>G (p.Leu320Val; p.L320V)
c.971G>T (p.Gly324Val; p.G324V)
c.977T>C (p.Val326Ala; p.V326A)
c.990dupT (p.Glu331Terfs)
c.991T>C (p.Cys331Arg; p.C331R)
SNP rs11316888 (intron variant)
SNP rs12022011 (intron variant)
619 bp deletion (g.71609_72227del619)
c.1000C>T (p.Arg334Trp; R334W)
c.1040G>A (p.Arg347His; R347H)
c.1062+5G>A (IVS12+5 G>A)
c.-119_-116delGTCA (5'UTR-119delGTCA)
c.126_129delCTTT (p.Phe42fs)
c.1316G>A; (p.Gly439Asp; p.G439D)
c.1327_1330dup (p.Ile444Argfs)
c.1364C>A (p.Ala455Glu; A455E)
c.1436C>T (p.P479L; p.Pro479Leu)
c.1466C>A (p.Ser489X; S489X)
c.1519_1521delATC (p.Ile507del; I507del; DI507)
c.1521_1523delCTT (p.Phe508del; F508del; dF508)
c.1523T>G (p.Phe508Cys; F508C)
c.1558G>T (p.Val520Phe; V520F)
c.1624G>T (p.Gly542X; G542X)
c.1646G>A (p.Ser549Asn; S549N)
c.1652G>A (p.Gly551Asp; G551D)
c.1657C>T (p.Arg553X; R553X)
c.1675G>A (p.Ala559Thr; A559T)
c.1679G>C (p.Arg560Thr; R560T)
c.1705T>G (p.Tyr569Asp; Y569D)
c.178G>T (p.Glu60X; E60X)
c.192G>T (p.Gln64His; Q64H)
c.199 T>C (p.Tyr67His; p.Y67H))
c.200C>T (p.Pro67Leu; P67L)
c.220G>A (p.Asp74Asn; Hb G-Accra; Korle-Bu variant of Hb)
c.223G>C (p.Asp74Gly; HbQ-Thailand)
c.2246G>T (p.R749L; p.Arg749Leu)
c.233C>A (p.Pro78His; HbToulon)
c.237C>A (p.Asn79Lys; HbStanleyville-II)
c.254G>A (p.Gly85Glu; G85E)
c.262_263delTT (p.Leu88IlefsX22; 394delTT)
c.2657+2_2657+3insA (2789+2insA)
c.27dupG (c.27_28insG; p.Ser10Valfs*14)
c.350G>A (p.Arg117His;R117H)
c.307A>C (p.Ser103Arg; HbManitoba I)
c.3080T>C (p.Ile1027Thr; I1027T)
c.3276C>A (p.Tyr1092X; Y1092X)
c.3276C>G (p.Tyr1092X; Y1092X)
c.3454G>C (p.Asp1152His; D1152H)
c.3484C>T (p.Arg1162X; R1162X)
c.364G>C (p.Glu121Gln; HbD)
c.364G>C (p.Glu121Gly; HbD-Punjab; Hb D-Los Angelese)
c.3659delC (p.Thr1220LysfsX8)
c.3717+12191C>T (3849+10kbC>T)
c.3731G>A (p.Gly1244Glu; G1244E)
c.3773_3774insT (3905insT)
c.3808G>A (p.Asp1270Asn; D1270N)
c.3909C>G (p.Asn1303Lys; N1303K)
c.3937C>T (p.Gln1313X; Q1313X)
c.427T>C (p.Ter143Glnext32; HbCS; HbConstant Spring)
c.46G>C (p.Gly15Arg; HbOttawa)
c.513C>G (p.Asp171Glu; p.D171E)
c.563A>G (p.Gln188Arg; p.Q188R)
c.617T>G (p.Leu206Trp; L206W)
c.744-33GATT[6]+[6] (TTAG repeats)
c.744-33GATT[6]+[7] (TTAG repeats)
c.782C>T (p.Pro261Leu; P261L)
c.799 G>A (p.Gly267Arg; p.G267R)
c.79G>A (p.Glu27Lys; HbE)
c.889_891del (p.Glu297del; p.E297del))
c.91+5G>T (IVS1+5G>T; IVS2+5G>T)
c.91G>A (p.Glu31Gln; HbG-Honolulu)
c.940A>G (p.Asn314Asp; N314D)
c.98_104delGCGGCTGinsTCC (p.Cys33Phefs; c.98_104del7ins3)
c.985A>G (p.Lys329Glu; p.K329E)
-α3.7 (3.7-kb rightward deletion)
-α4.2 (4.2-kb leftward deletion)
|
NDERFGNPRSHMY
|
Gene Variant Presumed Homozygous flag
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Gene Variant Presumed Homozygous flag
|
NDERFGNVROTHER
|
NSODERF Gene Variant Other
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
NSODERF Gene Variant Other
|
NDERFHCPINFR
|
DERF HCP not informed reason
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
DERF HCP not informed reason
Pick List Value:
Awaiting call back from parents
Incorrect contact information
No contact information for primary health care provider
Phone number out of service
Awaiting call back from primary health care provider
Unable to contact health care provider
Transferred to another treatment centre
Incorrect health care provider listed
No voice mail to leave message
Registered mail undeliverable
CAS involved to help locate
Family / parents out of country
No health care provider indicated
Parents contacted directly
No contact information for family
|
NDERFMAROHIP
|
NSO Missed Case Maternal Name and OHIP Note
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
The name and Ontario Health Card Number (if available) of the mother whose infant is affected with a disease on the NSO panel and was not diagnosed via newborn screening. Enter Unknown, CAS or adoption if applicable
|
NDERFMUTPOLY
|
NSO DERF Were mutations / polymorphism/deletions/duplications detected?
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
NSO DERF Were mutations / polymorphism/deletions/duplications detected?
|
NDERFNODEF
|
Reason for no definitive diagnosis established
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Please make a selection if the infant was lost to follow-up, or was deceased prior to establishment of diagnosis, or if no definitive diagnosis could be established for some reason.
** IF INFANT IS UNAFFECTED or a CARRIER (PRESUMED OR CONFIRMED), this is a "Definitive Diagnosis". Please click below and select "unaffected" or "carrier".
|
NDERFNODEFC
|
Reason comments for no definitive diagnosis established
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
|
NDERFNRF
|
Infant Not Referred Followup
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Indicates that the infant was not referred for followup
|
NDERFNRR
|
Reason Infant Was Not Referred NSO Followup
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Reason Infant Was Not Referred for NSO Followup
Pick List Value:
Infant under 24 hours at sample collection and a normal repeat received
Infant under 24hrs at sample collection, no repeat received as infant is deceased
SCID prem, infant screen negative on repeat
SCID prem, infant deceased
SCID prem, infant referred on repeat
CH positive <24 hours, not referred, awaiting repeat
SCID prem, not referred, awaiting repeat
|
NDERFOBT
|
Was NSO obtained?
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
An indication of whether a dried blood spot was obtained for newborn screening in Ontario as reported to the health care provider completing the SDRF
|
NDERFOBTJURFG
|
Was newborn screening obtained in another jurisdiction?
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
An indication of whether a dried blood spot or other sample type was obtained for newborn screening in a location other than Ontario as reported to the health care provider completing the SDRF.
|
NDERFOBTJURS
|
Specify jurisdiction
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The location where the infant's newborn screening sample was obtained if it was obtained in a jurisdiction other than Ontario
|
NDERFRESAPP
|
DERF results appended?
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Indicates whether the treatment centre will fax results from the diagnostic investigations performed on the referred infant to NSO. If checked, please print a copy of the DERF / SDRF and fax DERF / SDRF and appropriate investigations to NSO at the given fax number
|
NDERFRESAPPDET
|
DERF results appended details
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Investigations specified to be faxed to NSO at the given fax number
|
NDERFRESPOS11
|
NSO DERF Was the result a true positive
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Pick List Value:
Primary Target - Variant or Indeterminate
Secondary Target - Variant or Indeterminate
Persistent laboratory abnormalities
Maternal persistent laboratory abnormalities
|
NDERFREVD
|
DERF review date
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
DERF review date
|
NDERFSHARE
|
Share information with NSO
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Parents/guardians have requested that the diagnostic evaluation information not be shared with NSO.
|
NDERFTND
|
Test Not Done
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Indicates that the diagnostic investigation was not performed
|
NDERFUSRADD
|
DERF is user added
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
DERF is user added
|
NSODDTINIT
|
Diagnostic testing pending or initiated flag
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
|
NSODERF756
|
Family History of dyshormonogenesis
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
|
NSODERF757
|
How dyshormonogenesis diagnosis was made
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
|
NSODERF931
|
Is further information needed from the Treatment Centre
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
|
NSODERF932
|
NSO Reviewed By
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
|
NSODERF933
|
NSO Reviewed By Other
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
|
NSODERF934
|
Additional Review Questions
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
|
NSODERF935
|
NSO Review Comments
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
|
NSODERFCHTS
|
NSO DERF CH Thyroid Scan
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Results of the nuclear medicine examination using a radioactive iodine tracer to determine thyroid location and function
|
NSODERFCHUSIMG
|
NSO DERF CH Imaging by Ultrasound
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Imaging results of the thyroid gland
Pick List Value:
No thyroid tissue seen (Athyrotic)
|
NSODERFGTM
|
Genetic Testing Methodology
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Genetic testing methodology
Pick List Value:
Sequencing \ Single Gene Sequencing
Sequencing \ Gene Panel Sequencing
Deletion/Duplication \ FISH
Deletion/Duplication \ Microarray
Deletion/Duplication \ MLPA
Deletion/Duplication \ QPCR
|
NSODERFPHCONF
|
NSODERF Gene Variant Phase Confirmed flag
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
NSODERF Gene Variant Phase Confirmed flag
|
NSODERFUS
|
NSO DERF Ultrasound
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Imaging results of the gonads
|
NSOFUADDQ
|
NSO Follow-Up Additional Review Questions
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
NSO Follow-Up Additional Review Questions
|
NSOFUDIAGDT
|
Date of Diagnostic evaluation
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Date of Diagnostic evaluation
|
NSOFUGNALL1OTHE
|
NSO DERF Gene Allele 1 Other
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
NSO DERF Gene Allele 1 Other
|
NSOFUGNALL2OTHE
|
NSO DERF Gene Allele 2 Other
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
NSO DERF Gene Allele 2 Other
|
NSOFUGNALLELE1
|
NSO DERF Gene Allele 1
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
NSO DERF Gene Allele 1
Pick List Value:
c.443T>C (p.Ile148Asn; p.I148N)
c.470G>A (p.Arg157His; p.R157H)
c.473G>A (p.Arg158Gln; p.R158Q)
c.507delG (p.Glu169AspfsX11)
c.50G>A (p.Gly17Asp; Hb J-Baltimore)
c.511G>A (p.Ala171Thr; p.A171T)
c.518T>A (p.Ile173Asn; p.I173N)
c.51C>G (p.Phe17Leu; p.F17L)
c.535G>T (p.Gly179Trp; p.G179W)
c.547C>T (p.Arg183Trp; p.R183W)
c.556C>T (p.Arg186Trp; p.R186W)
c.556C>T (p.His186Tyr; p.H186Y)
c.557G>A (p.Cys186Tyr; p.C186Y)
c.56_57delGCinsAA (p.Arg19Gln; p.R19Q)
c.568C>T (p.His190Tyr; p.H190Y)
c.572T>C (p.Met191Thr; p.M191T)
c.575T>G (p.Phe192Cys; p.F192C)
c.577C>T (p.Arg193Trp; p.R193W)
c.604T>C (p.Phe202Leu; p.F202L)
c.629A>G (p.Tyr210Cys; p.Y210C)
c.631C>T (p.Arg211Cys; p.R211C)
c.632G>A (p.Arg211His; p.R211H)
c.638T>C (p.Leu213Pro; p.L213P)
c.641A>C (p.Asn214Thr; p.N214T)
c.641A>G (p.Asn214Ser; p.N214S)
c.641T>A (p.Ile214Lys; p.I214K)
c.645C>T (p.Leu215Leu; p.L215L)
c.64C>T (p.Pro22Ser; p.P22S)
c.652C>T (p.Leu218Leu; p.L218L)
c.656G>A (p.Arg219His; p.R219H)
c.658_660delAAG (p.Lys220del)
c.680A>T (p.Asp227Val; p.D227V)
c.682G>T (p.Asp228Tyr; D228Y)
c.683A>G (p.Asn228Ser; p.N228S)
c.701C>T (p.Thr234Ile; p.T234I)
c.701G>A (p.Arg234Gln; p.R234Q)
c.709G>A (p.Ala237Thr; p.A237T)
c.710T>A (p.Ile237Asn; p.I237N)
c.713T>A (p.Val238Glu; p.V238E)
c.719T>A (p.Met240Lys; p.M240K)
c.722G>A (p.Arg241His; p.R241H)
c.728G>A (p.Arg243Gln; p.R243Q)
c.734T>C (p.Val245Ala; p.V245A)
c.757G>A (p.Asp253Asn; p.D253N)
c.775C>T (p.Arg259Trp; p.R259W)
c.779C>T (p.Thr260Met; p.T260M)
c.782G>A (p.Arg261Gln; R261Q)
c.787G>A (p.Val263Met; p.V263M)
c.855G>T (p.Lys285Asn; p.K285N)
c.8591A>C (p.His2864Pro; p.H2864P)
c.860G>A (p.Gly287Asp; p.G287D)
c.865G>A (p.Gly289Arg; p.G289R)
c.877G>A (p.Ala293Thr; p.A293T)
c.881G>A (p.Gly294Glu; p.G294E)
SNP rs150422765 (intron variant)
c.887_888delCT (p.Pro296Argfs)
c.887G>A (p.Arg296Gln; p.R296Q)
c.895C>T (p.Arg299Cys; p.R299C)
c.896_898delAGA (p.Lys299del)
c.896A>T (p.Lys299Met; p.K299M)
c.896C>T (p.Ala299Val; p.A299V)
c.896T>G (p.Phe299Cys; p.F299C)
c.898G>T (p.Ala300Ser; p.A300S)
c.916A>G (p.Ile306Val; p.I306V)
c.923dupT (p.Leu308Phefs)
c.925G>A (p.Gly309Arg; p.G309R)
c.92C>T (p.Pro31Leu; p.P31L)
c.92G>C (p.Arg31Thr; Hb Kairouan)
c.937C>T (p.Arg313Trp; p.R313W)
c.939A>G (p.Ile313Met; p.I313M)
c.950T>C (p.Val317Ala; p.V317A)
c.956C>T (p.Ser319Phe; p.S319F)
c.958T>G (p.Leu320Val; p.L320V)
c.971G>T (p.Gly324Val; p.G324V)
c.977T>C (p.Val326Ala; p.V326A)
c.990dupT (p.Glu331Terfs)
c.991T>C (p.Cys331Arg; p.C331R)
SNP rs11316888 (intron variant)
SNP rs12022011 (intron variant)
c.1001A>G (p.Lys334Arg; p.K334R)
c.1009_1011del (p.Leu337del)
c.100G>A (p.Gly34Ser; p.G34S)
c.1010A>C (p.Tyr337Ser; p.Y337S)
c.1016C>T (p.Ser339Leu; p.S339L)
c.1027G>C (p.Gly343Arg; p.G343R)
c.1040G>C (p.Arg347Pro; p.R347P)
c.1045C>T (p.Arg349Ter; p.R349X)
c.1046C>T (p.Ala349Val; p.A349V)
c.1049 C>A (p.Ser350Tyr; p.S350Y)
c.105_109del (p.Arg37Alafs*20)
c.1052delC (p.Thr351Lysfs*12; p.T351Kfs*12)
c.1115C>A (p.Ala372Asp; p.A372D)
c.1135G>A (p.Ala379Thr; p.A379T)
c.1148T>A (p.Phe383Tyr; p.F383Y)
c.1168G>A (p.Gly390Arg; p.G390R)
c.1169A>G (p.Glu390Gly; p.E390G)
c.1171C>T (p.Pro391Ser; p.P391S)
c.1173C>A (p.Phe391Leu; p.F391L)
c.1193C>A (p.Ala398Asp; p.A398D)
c.1208C>T (p.Ala403Val; p.A403V)
c.1213A>G (p.Met405Val; p.M405V)
c.1222C>T (p.Arg408Trp; p.R408W)
c.1241A>G (p.Tyr414Cys; p.Y414C)
c.1247T>C (p.Ile416Thr; p.I416T)
c.1253G>A (p.Ser418Asn; p.S418N)
c.1312T>A (p.Tyr438Asn; p.Y438N)
c.1322G>A (p.Gly441Asp; p.G441D)
c.1324G>T (p.Val442Phe; p.V442F)
c.133G>A (p.Gly45Arg; p.G45R)
c.1348T>G (p.Trp450Gly; p.W450G)
c.1360G>A (p.Asp454Asn; p.D454N)
c.1361A>G (p.Tyr454Cys; p.Y454C)
c.1363delC (p.Leu455Phefs)
c.1367G>A (p.Arg456His; p.R456H)
c.1375dupC (p.Arg459Profs)
c.1376G>A (p.Arg459Gln; p.R459Q)
c.1388G>A (p.Gly463Glu; p.G463E)
c.1408A>G (p.Met470Val; M470V)
c.142G>C (p.Asp48His; Hb Hasharon)
c.143T>C (p.Leu48Ser; p.L48S)
c.1451_1452delGGinsC (p.Arg484Profs)
c.1451A>G (p.His484Arg; p.H484R)
c.1475A>C (p.Asp492Ala; p.D492A)
c.1475C>T (p.Thr492Ile; p.T492I)
c.1489C>T (p.Pro497Ser; p.P497S)
c.1500_1502del (p.Leu502del)
c.151C>T (p.His51Tyr; p.H51Y)
c.1528G>C (p.Glu510Gln; p.E510Q)
c.157C>T (p.Arg53Cys; p.R53C)
c.157G>A (p.Asp53Asn; Hb Osu Christiansborg)
c.1584G>A (p.Glu528Glu; p.E528E)
c.1603C>G (p.Leu535Val; p.L535V)
c.1612C>T (p.Arg538Cys; p.R538C)
c.1616A>G (p.Gln539Arg; p.Q539R)
c.1700G>A (p.Arg567Gln; p.R567Q)
c.-170G>A (Sardinian HPFH)
c.1727G>C (p.Gly576Ala; p.G576A)
c.1741G>T (p.Val581Phe; p.V581F)
c.1793A>G (p.His598Arg; p.H598R)
c.1844G>A (p.Arg615Gln; p.R615Q)
c.1868G>T (p.Gly623Val; p.G623V)
c.194T>C (p.Ile65Thr; p.I65T)
c.19G>A (p.Asp7Asn; Hb Dunn)
c.1A>G (p.Met1Val; p.M1V)
c.2002C>T (p.Arg668Cys; p.R668C)
c.200C>T (p.Thr67Met; p.T67M)
c.2015_2052delAAinsG (p.Lys684SerfsX38; 2183AA>G)
c.209C>T (p.Ser70Leu; p.S70L)
c.224G>A (p.Arg75Gln; R75Q)
c.2260G>A (p.Val754Met; V754M)
c.227T>C (p.Ile76Thr; Hb F Waynesboro)
c.227T>C (p.Leu76Pro; Hb Atlanta)
c.233T>C (p.Ile78Thr; p.I78T)
c.236G>A (p.Arg79His; p.R79H)
c.253G>T (p.Gly85Cys; p.G85C)
c.2562T>G (p.Thr854Thr; 2694T>G)
c.262_264delGAG (p.Glu88del; p.E88del)
c.276G>T (p.Glu92Asp; p.E92D)
c.281 A>G (p.Asp94Gly; p.D94G)
c.283G>A (p.Asp95Asn; Hb F Columbus-GA)
c.287G>T (p.Gly96Val; p.G96V)
c.290A>T (p. Asp97Val; p.D97V)
c.3067_3072delTAGTG (p.Ile1023Serfs)
c.3196C>T (p.Arg1066Cys; p.R1066C)
c.3197G>A (p.Arg1066His; p.R1066H)
c.3222T>A (p.Phe1074Leu; p.F1074L)
c.332_339delGAGACTAC (p.Gly111Valfs)
c.349C>T (p.Arg117Cys; p.R117C)
c.34G>A (p.Ala12Thr; p.A12T)
c.362C>T (p.Thr121Ile; p.T121I)
c.366T>G (p.Asn122Lys; p.D122K)
c.372T>A (p.Asp142Glu; p.D142E)
c.377G>A (p.Gly126Asp; p.G126D)
c.3794G>T (p.Gly1265Val; p.G1265V)
c.380C>T (p.Pro127Leu; p.P127L)
c.382_384delTAC (p.Tyr128del)
c.383_385del (p.Val128del)
c.3846G>A (p.Trp1282Ter; W1282X)
c.3889dupT(p.Ser1297Phefs*5)
c.3905T>C (p.Met1302Thr; p.M1302T)
c.394C>T (p.Arg132Stop; p.R132X)
c.397G>T (p.Val133Leu; p.V133L)
c.4272C>T (p.Tyr1424Tyr; p.Y1424Y)
c.428A>G (p.Asp143Gly; p.D143G)
c.436C>T (p.Arg146Trp; pR146W)
c.437delT (p.Leu146Trpfs)
c.4389G>A (p.Gln1463Gln; p.Q1463Q)
c.43G>T (p.Gly15Trp; p.G15W)
c.44 T>C (p.Val5Ala; p.V5A)
c.442delA (p.Ile148Leufs)
c.443A>G (p.Gln148Arg; p.Q148R)
c.443C>T (p.Thr148Ile; p.T148I)
c.443G>A (p.Arg148Lys; p.R148K)
619 bp deletion (g.71609_72227del619)
c.1000C>T (p.Arg334Trp; R334W)
c.1040G>A (p.Arg347His; R347H)
c.1062+5G>A (IVS12+5 G>A)
c.-119_-116delGTCA (5'UTR-119delGTCA)
c.126_129delCTTT (p.Phe42fs)
c.1316G>A; (p.Gly439Asp; p.G439D)
c.1327_1330dup (p.Ile444Argfs)
c.1364C>A (p.Ala455Glu; A455E)
c.1436C>T (p.P479L; p.Pro479Leu)
c.1466C>A (p.Ser489X; S489X)
c.1519_1521delATC (p.Ile507del; I507del; DI507)
c.1521_1523delCTT (p.Phe508del; F508del; dF508)
c.1523T>G (p.Phe508Cys; F508C)
c.1558G>T (p.Val520Phe; V520F)
c.1624G>T (p.Gly542X; G542X)
c.1646G>A (p.Ser549Asn; S549N)
c.1652G>A (p.Gly551Asp; G551D)
c.1657C>T (p.Arg553X; R553X)
c.1675G>A (p.Ala559Thr; A559T)
c.1679G>C (p.Arg560Thr; R560T)
c.1705T>G (p.Tyr569Asp; Y569D)
c.178G>T (p.Glu60X; E60X)
c.192G>T (p.Gln64His; Q64H)
c.199 T>C (p.Tyr67His; p.Y67H))
c.200C>T (p.Pro67Leu; P67L)
c.220G>A (p.Asp74Asn; Hb G-Accra; Korle-Bu variant of Hb)
c.223G>C (p.Asp74Gly; HbQ-Thailand)
c.2246G>T (p.R749L; p.Arg749Leu)
c.233C>A (p.Pro78His; HbToulon)
c.237C>A (p.Asn79Lys; HbStanleyville-II)
c.254G>A (p.Gly85Glu; G85E)
c.262_263delTT (p.Leu88IlefsX22; 394delTT)
c.2657+2_2657+3insA (2789+2insA)
c.27dupG (c.27_28insG; p.Ser10Valfs*14)
c.350G>A (p.Arg117His;R117H)
c.307A>C (p.Ser103Arg; HbManitoba I)
c.3080T>C (p.Ile1027Thr; I1027T)
c.3276C>A (p.Tyr1092X; Y1092X)
c.3276C>G (p.Tyr1092X; Y1092X)
c.3454G>C (p.Asp1152His; D1152H)
c.3484C>T (p.Arg1162X; R1162X)
c.364G>C (p.Glu121Gln; HbD)
c.364G>C (p.Glu121Gly; HbD-Punjab; Hb D-Los Angelese)
c.3659delC (p.Thr1220LysfsX8)
c.3717+12191C>T (3849+10kbC>T)
c.3731G>A (p.Gly1244Glu; G1244E)
c.3773_3774insT (3905insT)
c.3808G>A (p.Asp1270Asn; D1270N)
c.3909C>G (p.Asn1303Lys; N1303K)
c.3937C>T (p.Gln1313X; Q1313X)
c.427T>C (p.Ter143Glnext32; HbCS; HbConstant Spring)
c.46G>C (p.Gly15Arg; HbOttawa)
c.513C>G (p.Asp171Glu; p.D171E)
c.563A>G (p.Gln188Arg; p.Q188R)
c.617T>G (p.Leu206Trp; L206W)
c.744-33GATT[6]+[6] (TTAG repeats)
c.744-33GATT[6]+[7] (TTAG repeats)
c.782C>T (p.Pro261Leu; P261L)
c.799 G>A (p.Gly267Arg; p.G267R)
c.79G>A (p.Glu27Lys; HbE)
c.889_891del (p.Glu297del; p.E297del))
c.91+5G>T (IVS1+5G>T; IVS2+5G>T)
c.91G>A (p.Glu31Gln; HbG-Honolulu)
c.940A>G (p.Asn314Asp; N314D)
c.98_104delGCGGCTGinsTCC (p.Cys33Phefs; c.98_104del7ins3)
c.985A>G (p.Lys329Glu; p.K329E)
-α3.7 (3.7-kb rightward deletion)
-α4.2 (4.2-kb leftward deletion)
|
NSOFUGNALLELE2
|
NSO DERF Gene Allele 2
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Pick List Value:
c.44 T>C (p.Val5Ala; p.V5A)
c.442delA (p.Ile148Leufs)
c.443A>G (p.Gln148Arg; p.Q148R)
c.443C>T (p.Thr148Ile; p.T148I)
c.443G>A (p.Arg148Lys; p.R148K)
c.443T>C (p.Ile148Asn; p.I148N)
c.470G>A (p.Arg157His; p.R157H)
c.473G>A (p.Arg158Gln; p.R158Q)
c.507delG (p.Glu169AspfsX11)
c.50G>A (p.Gly17Asp; Hb J-Baltimore)
c.511G>A (p.Ala171Thr; p.A171T)
c.518T>A (p.Ile173Asn; p.I173N)
c.51C>G (p.Phe17Leu; p.F17L)
c.535G>T (p.Gly179Trp; p.G179W)
c.547C>T (p.Arg183Trp; p.R183W)
c.556C>T (p.Arg186Trp; p.R186W)
c.556C>T (p.His186Tyr; p.H186Y)
c.557G>A (p.Cys186Tyr; p.C186Y)
c.56_57delGCinsAA (p.Arg19Gln; p.R19Q)
c.568C>T (p.His190Tyr; p.H190Y)
c.572T>C (p.Met191Thr; p.M191T)
c.575T>G (p.Phe192Cys; p.F192C)
c.577C>T (p.Arg193Trp; p.R193W)
c.604T>C (p.Phe202Leu; p.F202L)
c.629A>G (p.Tyr210Cys; p.Y210C)
c.631C>T (p.Arg211Cys; p.R211C)
c.632G>A (p.Arg211His; p.R211H)
c.638T>C (p.Leu213Pro; p.L213P)
c.641A>C (p.Asn214Thr; p.N214T)
c.641A>G (p.Asn214Ser; p.N214S)
c.641T>A (p.Ile214Lys; p.I214K)
c.645C>T (p.Leu215Leu; p.L215L)
c.64C>T (p.Pro22Ser; p.P22S)
c.652C>T (p.Leu218Leu; p.L218L)
c.656G>A (p.Arg219His; p.R219H)
c.658_660delAAG (p.Lys220del)
c.680A>T (p.Asp227Val; p.D227V)
c.682G>T (p.Asp228Tyr; D228Y)
c.683A>G (p.Asn228Ser; p.N228S)
c.701C>T (p.Thr234Ile; p.T234I)
c.701G>A (p.Arg234Gln; p.R234Q)
c.709G>A (p.Ala237Thr; p.A237T)
c.710T>A (p.Ile237Asn; p.I237N)
c.713T>A (p.Val238Glu; p.V238E)
c.719T>A (p.Met240Lys; p.M240K)
c.722G>A (p.Arg241His; p.R241H)
c.728G>A (p.Arg243Gln; p.R243Q)
c.734T>C (p.Val245Ala; p.V245A)
c.757G>A (p.Asp253Asn; p.D253N)
c.775C>T (p.Arg259Trp; p.R259W)
c.779C>T (p.Thr260Met; p.T260M)
c.782G>A (p.Arg261Gln; R261Q)
c.787G>A (p.Val263Met; p.V263M)
c.855G>T (p.Lys285Asn; p.K285N)
c.8591A>C (p.His2864Pro; p.H2864P)
c.860G>A (p.Gly287Asp; p.G287D)
c.865G>A (p.Gly289Arg; p.G289R)
c.877G>A (p.Ala293Thr; p.A293T)
c.881G>A (p.Gly294Glu; p.G294E)
SNP rs150422765 (intron variant)
c.887_888delCT (p.Pro296Argfs)
c.887G>A (p.Arg296Gln; p.R296Q)
c.895C>T (p.Arg299Cys; p.R299C)
c.896_898delAGA (p.Lys299del)
c.896A>T (p.Lys299Met; p.K299M)
c.896C>T (p.Ala299Val; p.A299V)
c.896T>G (p.Phe299Cys; p.F299C)
c.898G>T (p.Ala300Ser; p.A300S)
c.916A>G (p.Ile306Val; p.I306V)
c.923dupT (p.Leu308Phefs)
c.925G>A (p.Gly309Arg; p.G309R)
c.92C>T (p.Pro31Leu; p.P31L)
c.92G>C (p.Arg31Thr; Hb Kairouan)
c.937C>T (p.Arg313Trp; p.R313W)
c.939A>G (p.Ile313Met; p.I313M)
c.950T>C (p.Val317Ala; p.V317A)
c.956C>T (p.Ser319Phe; p.S319F)
c.958T>G (p.Leu320Val; p.L320V)
c.971G>T (p.Gly324Val; p.G324V)
c.977T>C (p.Val326Ala; p.V326A)
c.990dupT (p.Glu331Terfs)
c.991T>C (p.Cys331Arg; p.C331R)
SNP rs11316888 (intron variant)
SNP rs12022011 (intron variant)
c.1135G>A (p.Ala379Thr; p.A379T)
c.1148T>A (p.Phe383Tyr; p.F383Y)
c.1168G>A (p.Gly390Arg; p.G390R)
c.1169A>G (p.Glu390Gly; p.E390G)
c.1171C>T (p.Pro391Ser; p.P391S)
c.1173C>A (p.Phe391Leu; p.F391L)
c.1193C>A (p.Ala398Asp; p.A398D)
c.1208C>T (p.Ala403Val; p.A403V)
c.1213A>G (p.Met405Val; p.M405V)
c.1222C>T (p.Arg408Trp; p.R408W)
c.1241A>G (p.Tyr414Cys; p.Y414C)
c.1247T>C (p.Ile416Thr; p.I416T)
c.1253G>A (p.Ser418Asn; p.S418N)
c.1312T>A (p.Tyr438Asn; p.Y438N)
c.1322G>A (p.Gly441Asp; p.G441D)
c.1324G>T (p.Val442Phe; p.V442F)
c.133G>A (p.Gly45Arg; p.G45R)
c.1348T>G (p.Trp450Gly; p.W450G)
c.1360G>A (p.Asp454Asn; p.D454N)
c.1361A>G (p.Tyr454Cys; p.Y454C)
c.1363delC (p.Leu455Phefs)
c.1367G>A (p.Arg456His; p.R456H)
c.1375dupC (p.Arg459Profs)
c.1376G>A (p.Arg459Gln; p.R459Q)
c.1388G>A (p.Gly463Glu; p.G463E)
c.1408A>G (p.Met470Val; M470V)
c.142G>C (p.Asp48His; Hb Hasharon)
c.143T>C (p.Leu48Ser; p.L48S)
c.1451_1452delGGinsC (p.Arg484Profs)
c.1451A>G (p.His484Arg; p.H484R)
c.1475A>C (p.Asp492Ala; p.D492A)
c.1475C>T (p.Thr492Ile; p.T492I)
c.1489C>T (p.Pro497Ser; p.P497S)
c.1500_1502del (p.Leu502del)
c.151C>T (p.His51Tyr; p.H51Y)
c.1528G>C (p.Glu510Gln; p.E510Q)
c.157C>T (p.Arg53Cys; p.R53C)
c.157G>A (p.Asp53Asn; Hb Osu Christiansborg)
c.1584G>A (p.Glu528Glu; p.E528E)
c.1603C>G (p.Leu535Val; p.L535V)
c.1612C>T (p.Arg538Cys; p.R538C)
c.1616A>G (p.Gln539Arg; p.Q539R)
c.1700G>A (p.Arg567Gln; p.R567Q)
c.-170G>A (Sardinian HPFH)
c.1727G>C (p.Gly576Ala; p.G576A)
c.1741G>T (p.Val581Phe; p.V581F)
c.1793A>G (p.His598Arg; p.H598R)
c.1844G>A (p.Arg615Gln; p.R615Q)
c.1868G>T (p.Gly623Val; p.G623V)
c.194T>C (p.Ile65Thr; p.I65T)
c.19G>A (p.Asp7Asn; Hb Dunn)
c.1A>G (p.Met1Val; p.M1V)
c.2002C>T (p.Arg668Cys; p.R668C)
c.200C>T (p.Thr67Met; p.T67M)
c.2015_2052delAAinsG (p.Lys684SerfsX38; 2183AA>G)
c.209C>T (p.Ser70Leu; p.S70L)
c.224G>A (p.Arg75Gln; R75Q)
c.2260G>A (p.Val754Met; V754M)
c.227T>C (p.Ile76Thr; Hb F Waynesboro)
c.227T>C (p.Leu76Pro; Hb Atlanta)
c.233T>C (p.Ile78Thr; p.I78T)
c.236G>A (p.Arg79His; p.R79H)
c.253G>T (p.Gly85Cys; p.G85C)
c.2562T>G (p.Thr854Thr; 2694T>G)
c.262_264delGAG (p.Glu88del; p.E88del)
c.276G>T (p.Glu92Asp; p.E92D)
c.281 A>G (p.Asp94Gly; p.D94G)
c.283G>A (p.Asp95Asn; Hb F Columbus-GA)
c.287G>T (p.Gly96Val; p.G96V)
c.290A>T (p. Asp97Val; p.D97V)
c.3067_3072delTAGTG (p.Ile1023Serfs)
c.3196C>T (p.Arg1066Cys; p.R1066C)
c.3197G>A (p.Arg1066His; p.R1066H)
c.3222T>A (p.Phe1074Leu; p.F1074L)
c.332_339delGAGACTAC (p.Gly111Valfs)
c.349C>T (p.Arg117Cys; p.R117C)
c.34G>A (p.Ala12Thr; p.A12T)
c.362C>T (p.Thr121Ile; p.T121I)
c.366T>G (p.Asn122Lys; p.D122K)
c.372T>A (p.Asp142Glu; p.D142E)
c.377G>A (p.Gly126Asp; p.G126D)
c.3794G>T (p.Gly1265Val; p.G1265V)
c.380C>T (p.Pro127Leu; p.P127L)
c.382_384delTAC (p.Tyr128del)
c.383_385del (p.Val128del)
c.3846G>A (p.Trp1282Ter; W1282X)
c.3889dupT(p.Ser1297Phefs*5)
c.3905T>C (p.Met1302Thr; p.M1302T)
c.394C>T (p.Arg132Stop; p.R132X)
c.397G>T (p.Val133Leu; p.V133L)
c.4272C>T (p.Tyr1424Tyr; p.Y1424Y)
c.428A>G (p.Asp143Gly; p.D143G)
c.436C>T (p.Arg146Trp; pR146W)
c.437delT (p.Leu146Trpfs)
c.4389G>A (p.Gln1463Gln; p.Q1463Q)
c.43G>T (p.Gly15Trp; p.G15W)
c.1001A>G (p.Lys334Arg; p.K334R)
c.1009_1011del (p.Leu337del)
c.100G>A (p.Gly34Ser; p.G34S)
c.1010A>C (p.Tyr337Ser; p.Y337S)
c.1016C>T (p.Ser339Leu; p.S339L)
c.1027G>C (p.Gly343Arg; p.G343R)
c.1040G>C (p.Arg347Pro; p.R347P)
c.1045C>T (p.Arg349Ter; p.R349X)
c.1046C>T (p.Ala349Val; p.A349V)
c.1049 C>A (p.Ser350Tyr; p.S350Y)
c.105_109del (p.Arg37Alafs*20)
c.1052delC (p.Thr351Lysfs*12; p.T351Kfs*12)
c.1115C>A (p.Ala372Asp; p.A372D)
619 bp deletion (g.71609_72227del619)
c.1000C>T (p.Arg334Trp; R334W)
c.1040G>A (p.Arg347His; R347H)
c.1062+5G>A (IVS12+5 G>A)
c.-119_-116delGTCA (5'UTR-119delGTCA)
c.126_129delCTTT (p.Phe42fs)
c.1316G>A; (p.Gly439Asp; p.G439D)
c.1327_1330dup (p.Ile444Argfs)
c.1364C>A (p.Ala455Glu; A455E)
c.1436C>T (p.P479L; p.Pro479Leu)
c.1466C>A (p.Ser489X; S489X)
c.1519_1521delATC (p.Ile507del; I507del; DI507)
c.1521_1523delCTT (p.Phe508del; F508del; dF508)
c.1523T>G (p.Phe508Cys; F508C)
c.1558G>T (p.Val520Phe; V520F)
c.1624G>T (p.Gly542X; G542X)
c.1646G>A (p.Ser549Asn; S549N)
c.1652G>A (p.Gly551Asp; G551D)
c.1657C>T (p.Arg553X; R553X)
c.1675G>A (p.Ala559Thr; A559T)
c.1679G>C (p.Arg560Thr; R560T)
c.1705T>G (p.Tyr569Asp; Y569D)
c.178G>T (p.Glu60X; E60X)
c.192G>T (p.Gln64His; Q64H)
c.199 T>C (p.Tyr67His; p.Y67H))
c.200C>T (p.Pro67Leu; P67L)
c.220G>A (p.Asp74Asn; Hb G-Accra; Korle-Bu variant of Hb)
c.223G>C (p.Asp74Gly; HbQ-Thailand)
c.2246G>T (p.R749L; p.Arg749Leu)
c.233C>A (p.Pro78His; HbToulon)
c.237C>A (p.Asn79Lys; HbStanleyville-II)
c.254G>A (p.Gly85Glu; G85E)
c.262_263delTT (p.Leu88IlefsX22; 394delTT)
c.2657+2_2657+3insA (2789+2insA)
c.27dupG (c.27_28insG; p.Ser10Valfs*14)
c.350G>A (p.Arg117His;R117H)
c.307A>C (p.Ser103Arg; HbManitoba I)
c.3080T>C (p.Ile1027Thr; I1027T)
c.3276C>A (p.Tyr1092X; Y1092X)
c.3276C>G (p.Tyr1092X; Y1092X)
c.3454G>C (p.Asp1152His; D1152H)
c.3484C>T (p.Arg1162X; R1162X)
c.364G>C (p.Glu121Gln; HbD)
c.364G>C (p.Glu121Gly; HbD-Punjab; Hb D-Los Angelese)
c.3659delC (p.Thr1220LysfsX8)
c.3717+12191C>T (3849+10kbC>T)
c.3731G>A (p.Gly1244Glu; G1244E)
c.3773_3774insT (3905insT)
c.3808G>A (p.Asp1270Asn; D1270N)
c.3909C>G (p.Asn1303Lys; N1303K)
c.3937C>T (p.Gln1313X; Q1313X)
c.427T>C (p.Ter143Glnext32; HbCS; HbConstant Spring)
c.46G>C (p.Gly15Arg; HbOttawa)
c.513C>G (p.Asp171Glu; p.D171E)
c.563A>G (p.Gln188Arg; p.Q188R)
c.617T>G (p.Leu206Trp; L206W)
c.744-33GATT[6]+[6] (TTAG repeats)
c.744-33GATT[6]+[7] (TTAG repeats)
c.782C>T (p.Pro261Leu; P261L)
c.799 G>A (p.Gly267Arg; p.G267R)
c.79G>A (p.Glu27Lys; HbE)
c.889_891del (p.Glu297del; p.E297del))
c.91+5G>T (IVS1+5G>T; IVS2+5G>T)
c.91G>A (p.Glu31Gln; HbG-Honolulu)
c.940A>G (p.Asn314Asp; N314D)
c.98_104delGCGGCTGinsTCC (p.Cys33Phefs; c.98_104del7ins3)
c.985A>G (p.Lys329Glu; p.K329E)
-α3.7 (3.7-kb rightward deletion)
-α4.2 (4.2-kb leftward deletion)
|
NSOFUPHSCONF
|
NSODERF Phase Confirm Method
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
NSODERF Phase Confirm Method
|
NSOSTFU0020
|
NSO STFU Follow-Up Profile Profile Type
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
Not available to end user. Used to define types of profile for UI rendering
|
NSOSTFU003
|
NSO Gaining Weight Comment
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Comments regarding whether an infant with a positive newborn screen was gaining weight at the time of retrieval for diagnostic evaluation
|
NSOSTFU012
|
NSO STFU Follow-Up Profile Diagnostic Analyte Name
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The name(s) of the analyte(s) measured in the diagnostic evaluation of the infant / child
Pick List Value:
Anti-Thyroid Peroxidase (TPO)
Succinylacetone, dried blood spot
C14 acylcarnitine, Plasma
C14:1 acylcarnitine, Plasma
C16 acylcarnitine, Plasma
C16:1 acylcarnitine, Plasma
3-OH Glutaric Acid, Urine
C5DC acylcarnitine, Plasma
C18 acylcarnitine, Plasma
Gal-1-P Uridyl Transferase, RBC
C10 acylcarnitine, Plasma
Galactose-1-Phosphate, RBC
C18:2 acylcarnitine, Plasma
C14:1OH acylcarnitine, Plasma
C14OH acylcarnitine, Plasma
C16:1OH acylcarnitine, Plasma
C16OH acylcarnitine, Plasma
C18:1 acylcarnitine, Plasma
C18:1OH acylcarnitine, Plasma
C18OH acylcarnitine, Plasma
Total Carnitine, Plasma Newborn
Free Carnitine, Plasma Newborn
Creatinine, Plasma Newborn
Total Carnitine, Urine Newborn
Free Carnitine, Urine Newborn
Creatinine, Urine Newborn
Specify FE Carnitine or TRR% and value
Total Carnitine, Plasma Mother
Free Carnitine, Plasma Mother
Creatinine, Plasma Mother
Total Carnitine, Urine Mother
Free Carnitine, Urine Mother
C5OH acylcarnitine, Plasma
C5:1 acylcarnitine, Plasma
C6DC acylcarnitine, Plasma
Thyroid Scan/Ultrasound (size)
C4DC acylcarnitine, Plasma
Total Homocysteine, Plasma Newborn
Total Homocysteine, Maternal Plasma
Hydroxylysine / allo-Hydroxylysine
Repeat NSO TREC on dried blood spot
|
NSOSTFU012I
|
Molecular Result Interpretation
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The interpretation of the results of the molecular investigations
Pick List Value:
Non-Pathogenic Polymorphism – Previously Reported
Pathogenic Mutation - Previously Reported
Presumed Non-Pathogenic Polymorphism – Previously Reported
Presumed Non-Pathogenic Polymorphism – Previously Unreported
Presumed Pathogenic Mutation - Previously Reported
Presumed Pathogenic Mutation – Previously Unreported
Variant of Unknown Significance – Previously Reported
Variant of Unknown Significance - Previously Unreported
|
NSOSTFU013
|
NSO STFU Follow-Up Profile Diagnostic Analyte Value
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The numeric or alpha numeric value (result) of the analyte measured in the diagnostic evaluation of the infant / child
|
NSOSTFU014
|
NSO STFU Follow-Up Profile Result
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The result of the profile performed in the diagnostic evaluation of the infant / child.
|
NSOSTFU014TXT
|
NSO STFU Follow-Up Profile Result Test
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The result of the profile performed in the diagnostic evaluation of the infant / child.
|
NSOSTFU015
|
Etiology of transient CH
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The etiology of the newborn's transient congenital hypothyroidism as determined after diagnostic investigations and evaluations following a positive newborn screen
Pick List Value:
Maternal PTU / Grave's treatment
Thyroid blocking antibodies
Other known cause, specify:
|
NSOSTFU015-01
|
Etiology of transient CH, other
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
An indication of the cause of the transient congenital hypothyroidism in the infant with a positive newborn for CH excluding maternal PTU/Grave's treatment, thyroid blocking antibodies and prematurity
|
NSOSTFU016
|
Hemoglobin method after positive newborn screen
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The method by which an infant's hemoglobin pattern and the percentages of each hemoglobin detected are determined after a positive newborn screen
|
NSOSTFU017
|
NSO STFU Follow-Up Profile Name
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Pick List Value:
Additional Diagnostic Investigations
Adrenocorticotropic hormone stimulation test
Repeat NSO purine profile on dried blood spot
Acylcarnitine profile (infant)
Acylcarnitine profile (mother)
Molecular results (in standard nomenclature)
Organic acid profile (newborn/patient)
Hemoglobin pattern determined by
Organic acid profile (maternal)
Acylcarnitine probe results
Palmitoyl-CoA-oxidation studies
|
NSOSTFU2001
|
Comments regarding the clinical status of the screen positive patient (for data element NBS0111)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Comments regarding the clinical status of the screen positive patient. If unwell is selected, please indicate the reason(s) why the infant was unwell at retrieval.
|
NSOSTFU2002
|
Comments regarding whether the infant was diagnosed prior to retrieval (for data element NBS0110)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Comments regarding whether the infant was diagnosed prior to retrieval (for data element NBS0110)
|
NSOSTFU2003
|
Comments regarding whether the infant was symptomatic of the disease prior to retrieval
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Comments regarding whether the infant had symptoms attributable to the disease for which they screened positive. If the infant did have symptoms, please specify symptoms here.
|
NSOSTFU2004
|
Comments regarding whether the infant was gaining weight at the time of retrieval
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Comments regarding whether the infant was gaining weight at the time of retrieval
|
NSOSTFU2005
|
Comments regarding whether the infant was hospitalized due to the screen positive disease at the time of retrieval
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Comments regarding whether the infant was hospitalized at the time of retrieval. If the infant was hospitalized at the time of retrieval, please specify reason(s) here.
|
NSOSTFU2006
|
Comments regarding whether the infant was virilised
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Comments regarding whether the infant was virilised
|
NSOSTFU2007
|
Comments regarding maternal steroids
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Comments regarding maternal steroids
|
NSOSTFU2008
|
Comments regarding family members of screen positive infant (for data element NBS0030, NBS0031, NBS0108, NBS0032)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Comments regarding family members of the screen positive infant(DERF) or the infant affected with an NSO target disease not ascertained by newborn screening (SDRF)
|
NSOSTFU2009
|
Comments regarding etiology of transient CH
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Comments regarding etiology of transient CH
|
NSOSTFU2010
|
Comments regarding ascertainment of missed cases (for data element D0131)
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Comments regarding ascertainment of infants with an NSO target disease who were not ascertained by newborn screening (for data element D0131)
|
NSOSTFU2030
|
Receive Entered Results CCPID Flag
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Receive Entered Results CCPID Flag
|
NSOSTFU2040
|
Receive Entered Results Flag
|
NSO Diagnostic Evaluation Report Form (DERF)
|
BORN collects this variable but due to personal health information (PHI) or sensitivity it is not available for data request.
Data Definition:
Receive Entered Results Flag
|
PSDP001
|
Prenatal Diagnostic Procedure Disposition
|
NSO Diagnostic Evaluation Report Form (DERF)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
An indication of whether a prenatal diagnostic procedure was offered, declined, accepted or unknown.
|
Y02091
|
Birth Hospital
|
Birth Child (BC), Healthy Babies Healthy Children (HBHC), Labour & Birth Mother (LBM), Newborn Screening Ontario (NSO), Neonatal Intensive Care Unit (NICU), NSO Diagnostic Evaluation Report Form (DERF), Postpartum Mother (PPM)
|
This variable is available for release but with restriction or approval from appropriate stakeholder.
Data Definition:
The name of the hospital where the birth occurred if Birth Location =hospital. Includes all Ontario hospitals with and without birthing units and some out of province and out of country hospitals.
|